(Q51585034)

7 April 2018

title

Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia. (English)

1 reference

7 April 2018

0 references

1 reference

1

1 reference

7 April 2018

author name string

Jennifer Sabino

2

1 reference

7 April 2018

Myrlene Gee

3

1 reference

7 April 2018

Thomas Bouchard

4

1 reference

7 April 2018

Nancy Fisher

5

1 reference

7 April 2018

Chris Hanstock

6

1 reference

7 April 2018

Derek Emery

7

1 reference

7 April 2018

W R Wayne Martin

8

1 reference

7 April 2018

language of work or name

English

0 references

publication date

25 March 2011

1 reference

7 April 2018

published in

Movement Disorders

1 reference

7 April 2018

volume

26

1 reference

7 April 2018

issue

8

1 reference

7 April 2018

page(s)

1443-1450

1 reference

7 April 2018

Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

cites work

1 reference

Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study.

21 January 2018

1 reference

Cognitive status correlates with neuropathologic stage in Parkinson disease

21 January 2018

1 reference

Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease

21 January 2018

1 reference

Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging.

21 January 2018

1 reference

Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline

21 January 2018

1 reference

Trajectories of brain loss in aging and the development of cognitive impairment

21 January 2018

1 reference

Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database

21 January 2018

1 reference

Asymmetrical lateral ventricular enlargement in Parkinson's disease.

21 January 2018

1 reference

Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies

21 January 2018

1 reference

The FAB: a Frontal Assessment Battery at bedside.

21 January 2018

1 reference

Validity of the Dementia Rating Scale in assessing cognitive function in Parkinson's disease.

21 January 2018

1 reference

Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease

21 January 2018

1 reference

Comparison of two screening tests in Alzheimer's disease. The correlation and reliability of the Mini-Mental State Examination and the modified Blessed test.

21 January 2018

1 reference

Validation of the Cumulative Illness Rating Scale in a geriatric residential population

21 January 2018

1 reference

The Clinical Dementia Rating (CDR): current version and scoring rules

21 January 2018

1 reference

Relationship between mild cognitive impairment and falls in older people with and without Parkinson's disease: 1-Year Prospective Cohort Study.

21 January 2018

1 reference

Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients.

21 January 2018

1 reference

A new rating scale for age-related white matter changes applicable to MRI and CT.

21 January 2018

1 reference

An optimized method for estimating intracranial volume from magnetic resonance images.

21 January 2018

1 reference

The epidemiology of dementia associated with Parkinson's disease

21 January 2018

1 reference

Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia.

21 January 2018

1 reference

Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia

21 January 2018

1 reference

CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease

21 January 2018

1 reference

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

21 January 2018

1 reference

Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline

21 January 2018

1 reference

Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson's disease

21 January 2018

1 reference

Clinical diagnostic criteria for dementia associated with Parkinson's disease

21 January 2018

1 reference

Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.

21 January 2018

1 reference

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

21 January 2018

1 reference

CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study

21 January 2018

1 reference

Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.23700

1 reference

7 April 2018

1 reference

7 April 2018